Catalyst Event
Cogent Biosciences Inc (COGT) · Other
From KEDI U.S. Next Tech TOP10 Index (KUNTT10)
5/30/2026, 12:00:00 AM
Announced detailed positive clinical data from the PEAK Phase 3 trial of bezuclastinib for GIST at the ASCO annual meeting on May 30, 2026; median PFS was 16.5 months vs 9.2 months. High importance estimated due to significant clinical data for lead candidate.
Korean Translation
2026년 5월 30일 ASCO 연례회의에서 위장관 기질 종양(GIST) 환자 대상 베주클라스티닙 3상 PEAK 임상시험 상세 데이터를 발표함. 주요 후보물질의 유의미한 임상 데이터로 높은 중요도가 예상됨.
Related Recent Events
AST SpaceMobile Inc (ASTS) · Earnings Release
Q2 2026 earnings release and conference call for August 10, 2026, which is expected to have a medium impact by providing key financial updates, scheduled.
8/10/2026, 12:00:00 AM
D-Wave Quantum Inc (QBTS) · Earnings Release
Next quarterly earnings report for Q2 2026 is scheduled for 2026-08-06; scheduled.
8/6/2026, 12:00:00 AM
Cogent Biosciences Inc (COGT) · Earnings Release
Q2 2026 earnings release on August 4, 2026; low importance estimated as scheduled earnings announcement expected.
8/4/2026, 12:00:00 AM
AeroVironment Inc (AVAV) · Earnings Release
AeroVironment is expected to release its Q4 and full fiscal year 2026 earnings results on or around June 29, 2026; high impact is estimated due to previous Q3 contract termination and impairment expected
6/29/2026, 12:00:00 AM
AST SpaceMobile Inc (ASTS) · Other
Launch of three BlueBird satellites (8, 9, and 10) via a SpaceX Falcon 9 rocket on June 15, 2026, which is expected to have a medium impact as a significant deployment milestone, scheduled.
6/15/2026, 12:00:00 AM
Cloudflare Inc (NET) · Other
Cloudflare is scheduled to host its 2026 Investor Day at the New York Stock Exchange to provide updates on strategy and financials. This event is estimated to have a 5% price impact as strategic roadmaps are revealed, scheduled.
6/9/2026, 12:00:00 AM